Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Rewisca
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Rewisca 75mg capsules
0408010AEBCADAC
|
Rewisca | Pregabalin | Central Nervous System | 19 |
|
Rewisca 150mg capsules
0408010AEBCAEAE
|
Rewisca | Pregabalin | Central Nervous System | 1 |
|
Rewisca 100mg capsules
0408010AEBCAAAD
|
Rewisca | Pregabalin | Central Nervous System | No data available |
|
Rewisca 200mg capsules
0408010AEBCAFAF
|
Rewisca | Pregabalin | Central Nervous System | No data available |
|
Rewisca 225mg capsules
0408010AEBCAGAI
|
Rewisca | Pregabalin | Central Nervous System | No data available |
|
Rewisca 25mg capsules
0408010AEBCABAA
|
Rewisca | Pregabalin | Central Nervous System | No data available |
|
Rewisca 300mg capsules
0408010AEBCAHAG
|
Rewisca | Pregabalin | Central Nervous System | No data available |
|
Rewisca 50mg capsules
0408010AEBCACAB
|
Rewisca | Pregabalin | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.